Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis - Wikidata - wikimedia - TriplyDB

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

http://www.wikidata.org/entity/Q36006859

about

The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats.Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.Bis-enoxacin blocks rat alveolar bone resorption from experimental periodontitis.Periodontitis in rats induces systemic oxidative stress that is controlled by bone-targeted antiresorptives Covalent Immobilization of Enoxacin onto Titanium Implant Surfaces for Inhibiting Multiple Bacterial Species Infection and In Vivo Methicillin-Resistant Staphylococcus aureus Infection Prophylaxis.Characterization of Regulatory Extracellular Vesicles from Osteoclasts.Bis-enoxacin inhibits bone resorption and orthodontic tooth movement Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.Reveromycin A-Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis.Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review.Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-κb and Nfatc1 Activities.Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis Vacuolar H+-ATPase: An Essential Multitasking Enzyme in Physiology and Pathophysiology

P2860

Q33770077-8CA713AD-5C52-4A7B-97A0-A3DCFF59B1CD Q34384846-812FBD44-CDF4-433E-9E37-0F55EA1492A9 Q35123218-40744582-2AF8-4E46-80BA-338F1C42A82C Q36019860-C3CD5570-3D08-473C-85A2-FE0E97006048 Q36178762-99471BD7-3330-4FD3-8260-08BB9E1C261D Q37046045-12D34F7D-7652-4E2A-BA09-6C72E839D735 Q37177844-5D64BD19-DA51-4BBA-B758-8B661A75C490 Q37661304-AE31542D-03ED-419F-BDA2-6CD518B37456 Q38205860-72BA4355-B980-4CF1-AFFA-DDFAFF5FE29E Q38901830-968967B6-61D4-418A-9122-DC422AE08A71 Q47400369-3D83A69F-715E-4E0A-936E-5015D60E2699 Q53838915-03FCD3FD-E170-4E0B-915A-9C9D6D5ECD9C Q58577597-F4E7EC26-90D4-4CAC-B71D-6F5CA0D49F16 Q59072675-0A19F07E-03AF-4276-8B38-A5E24190D042

P2860

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

http://www.wikidata.org/entity/Q36006859

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@ast

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@en

type

label

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@ast

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@en

prefLabel

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@ast

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@en

P1433

Q36006859-F7F5B00D-14D2-492C-A376-178EEF546730

P1476

Q36006859-65CF90C2-9665-4006-AEBD-02AE96817E60

P2093

Q36006859-2DC59AA0-6DA2-4FBA-B0DD-301DAAFB4BEB

Q36006859-321D7704-EE3B-4F0A-903E-ACCB2C49369D

Q36006859-5A342A3A-2DE0-4CBB-BBC6-F5717A9A1EF3

Q36006859-5F38F4FF-CEDC-4241-A586-948EF9CBF920

Q36006859-71A69980-1FDF-4AAE-BE55-D85E60383445

Q36006859-79F81F60-2012-4D60-B363-15245C0F833D

Q36006859-7D3ACFE8-F928-4183-B4A8-4E9BCB8B9ADE

Q36006859-89F08063-1169-4751-BCEE-CADB06AEE4DD

Q36006859-9B1F56FF-4215-4DE5-837E-47F9A2DFBFDB

Q36006859-F6A7179E-FBEC-4BFC-BC8E-3F356C93111E

P2860

Q36006859-034830F9-D593-46EB-B8CE-1960ED001DA9

Q36006859-0AC41C9A-5F30-45AF-BA39-51FBAC8373F8

Q36006859-0B016A57-1222-4CD7-86F6-E982B7656C4F

Q36006859-0E295881-E454-40E2-AD9C-87A700088E85

Q36006859-1012027A-F52B-41B4-8E83-A9A9F302C433

Q36006859-12071701-1E7F-4459-8E32-F354BE05EA6E

Q36006859-28B369E9-B509-43F5-91A8-E026369DC1D1

Q36006859-28FC8B39-DCDB-49EC-AC81-E6A6EE0E086B

Q36006859-2BBBCD07-B57B-4D4C-B866-C50EF35879AF

Q36006859-2C91BF1C-2A13-4603-B5A3-9C8B3A578993

P304

Q36006859-BBA40CAA-BE74-45CB-93EA-7A6E8AE22809

P31

Q36006859-445CE7C0-176C-4B5C-9C66-3D4DCF748580

P356

Q36006859-E537D98C-A867-4051-8918-39CFC936396E

P407

Q36006859-2DCBA902-709C-4F89-B74F-1E771A77060C

P433

Q36006859-B24D313E-AE44-4EA6-8840-88666F3DD880

P478

Q36006859-F25D8338-611A-48E6-8B06-CA108964ADCC

P50

Q36006859-299DBA28-79B5-4CD8-9D4B-4FE67E816DBB

P577

Q36006859-A5B665C7-DC31-467F-B925-344BB1D55204

P5875

Q36006859-FD8D2DCB-F2CB-4836-8374-11A0A3F02F36

P698

Q36006859-EF589D0F-C510-4C5D-8F06-B79E744AA470

P932

Q36006859-98CE09AD-1B90-4126-91A3-0073D2DCF67B

P356

JBC.M111.280511

P1433

Journal of Biological Chemistry

P1476

Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis

@en

P2093

Aliana R Caridad

http://www.w3.org/2001/XMLSchema#string

Dana Catalfamo

http://www.w3.org/2001/XMLSchema#string

David A Ostrov

http://www.w3.org/2001/XMLSchema#string

Edgardo J Toro

http://www.w3.org/2001/XMLSchema#string

Jian Zuo

http://www.w3.org/2001/XMLSchema#string

John K Neubert

http://www.w3.org/2001/XMLSchema#string

L Shannon Holliday

http://www.w3.org/2001/XMLSchema#string

Shannon M Wallet

http://www.w3.org/2001/XMLSchema#string

Thomas J Wronski

http://www.w3.org/2001/XMLSchema#string

Victor Arana-Chavez

http://www.w3.org/2001/XMLSchema#string

P2860

V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

Osteoclasts: what do they do and how do they do it?

The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation

Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A

Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

The amino-terminal domain of the B subunit of vacuolar H+-ATPase contains a filamentous actin binding site

History of quinolones and their side effects

RANKL-induced DC-STAMP is essential for osteoclastogenesis

Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells

P304

17894-17904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.280511

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P50

Vivian Bradaschia-Correa

P577

2012-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223986753

http://www.w3.org/2001/XMLSchema#string

P698

22474295

http://www.w3.org/2001/XMLSchema#string

P932

3366803

http://www.w3.org/2001/XMLSchema#string